首页> 外文期刊>针灸推拿医学(英文版) >腹针疗法治疗骨质疏松椎体压缩性骨折临床研究
【24h】

腹针疗法治疗骨质疏松椎体压缩性骨折临床研究

机译:腹针疗法治疗骨质疏松椎体压缩性骨折临床研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To explore the efficacy of abdominal acupuncture in treating patients with osteoporotic vertebral compression fracture (OVCF). Methods:Forty-five eligible OVCF patients were randomized into an abdominal acupuncture (AA) group, a body acupuncture (BA) group and a medication group according to the random numbers generated by the SPSS 11.5 version software, 15 subjects in each group. Patients in the medication group were intervened by Ossotide injection (intravenous injection), Caltrate (oral administration), Alfacalcidol (oral administration), and Salcatonin injection (muscular injection). In addition to the intervention given to the medication group, patients in the AA group additionally received acupuncture at Zhongwan (CV 12), Xiawan (CV 10), Qihai (CV 6), Guanyuan (CV 4), Shuifen (CV 9), and Huaroumen (ST 24); while patients in the BA group additionally received acupuncture at Jiaji (EX-B 2, superior and inferior to the affected area) points, Ashi points, Weizhong (BL 40) and Chengshan (BL 57). For the AA and BA groups, the acupuncture treatment was given once a day, 6 d per week, for 3 weeks in total. Prior to the intervention, and respectively after 1-week treatment, 2-week treatment and 3-week treatment, visual analogue scale (VAS) and Barthel index (BI) were adopted to evaluate pain degree and activities of daily living (ADL). Results:After intervention, the VAS and BI scores were significantly changed in the three groups (P<0.05). Respectively after 1-week, 2-week and 3-week treatment, the VAS and BI scores in the two acupuncture groups were significantly different from those in the medication group at the same time point (P<0.01). After 1-week and 2-week treatment, the improvements of VAS and BI scores in the AA group were more significant than those in the BA group(P<0.05); after 3-week treatment, there was no significant difference in comparing the VAS score between the two acupuncture groups (P>0.05), but a significant difference was found in comparing the BI score (P<0.05). Conclusion:Abdominal acupuncture can produce a more significant effect in improving VAS and BI scores in OVCF patients than body acupuncture and pure medication treatment, and it’s efficient and causes few sufferings.%目的:探索腹针疗法治疗骨质疏松椎体压缩性骨折(osteoporotic vertebral compression fracture, OVCF)患者的临床疗效。方法:符合纳入标准的45例OVCF患者,根据SPSS 11.5软件产生的随机数字随机为腹针组、体针组和药物组,每组15例。药物组患者予以骨肽注射液静滴、钙尔奇、阿法骨化醇软胶囊口服及鲑降钙素注射液肌注。腹针组患者在接受与药物组相同的药物治疗基础上接受针刺引气归元(中脘、下脘、气海、关元)、水分、滑肉门治疗;体针组患者在接受与药物组相同的药物治疗基础上接受针刺患处上下夹脊穴、阿是穴、委中和承山治疗。腹针组及体针组患者均每日针刺1次,每星期治疗6 d,休息1 d,共治疗3星期。于治疗前及治疗1、2、3星期后进行疼痛视觉模拟量表(visual analogue scale, VAS)及Barthel指数(Barthel index, BI)评分,分别评价患者的疼痛程度及日常生活能力(activities of daily living, ADL)。结果:治疗后,三组VAS评分及BI评分均与本组治疗前有统计学差异(P<0.05)。治疗1、2、3星期后,腹针组及体针组VAS及BI评分均与同期药物组评分有统计学差异(P<0.01)。治疗1、2星期后,腹针组VAS及BI评分改善程度优于体针组(P<0.05);治疗3星期后,腹针组与体针组的VAS评分差异无统计学意义(P>0.05), BI评分具有统计学差异(P<0.05)。结论:腹针疗法在改善OVCF患者VAS及BI评分方面优于体针及单纯药物治疗,且具有起效快,痛苦小的特点。
机译:目的:探讨腹针灸治疗骨质疏松椎体压缩骨折(OVCF)的疗效。方法:根据SPS 11.5版本软件,每个受试者,45例符合条件的OVCF患者随机分为腹针刺(AA)组,身体针灸(AA)组,身体针灸(BA)组和药物组,其中15个受试者团体。药物组中的患者通过OSSOTAID注射(静脉注射),Caltrate(口服给药),阿尔法丙酮醇(口服给药)和Salcatonin注射(肌肉注射液)。除了给予药物组的干预案外,AA组患者还在中湾(CV 12),夏湾(CV 10),Qiihai(CV 6),古南(CV 4),sh芬(CV 9),和Huaroumen(圣24);虽然BA组的患者另外在嘉吉(EX-B 2,优越和较差的区域)点,ASHI点,威尚(BL 40)和成山(BL 57)的针灸。对于AA和BA组,针灸治疗每天给予一次,每周6天,总共3周。在干预之前,采用2周治疗和3周治疗,采用2周治疗和3周的治疗,视觉模拟量表(VAS)和条形指数(BI)来评估日常生活的疼痛程度和活动(ADL)。结果:在干预后,三组中,VAS和BI分数显着变化(P <0.05)。分别在1周,2周和3周的治疗后,两个针灸组中的VAS和BI分数与同一时间点的药物组中的分数显着不同(P <0.01)。 1周和2周治疗后,AA组中的VAS和BI分数的改善比BA组的改善更重要(P <0.05); 3周治疗后,将两个针灸组之间的VAS得分比较(P> 0.05)之间没有显着差异,但在比较BI得分时发现显着差异(P <0.05)。结论:腹部针灸可以在改善OVCF患者的VAS和BI分数方面产生比身体针刺和纯粹的药物治疗更大的效果,并且效率且导致患有少数痛苦。%体压缩性骨折(骨质疏松椎体压缩骨折,OVCF)患者的临床临床。方法:综合纳入标准的45例OVCF患者,根据SPSS11.5软件软件产软件患者随随,体积产前的随机数据传导机为腹针组,体育和含有物,每组15例。药物组患者予以骨肽注液静滴,钙尔奇,阿法骨骨骨鲑鲑降注射液肌注。腹针组患者降钙素注射。基底上接受引气归元(中脘,下脘,气海,关闭),水分,滑肉门治疗;体内患者在接受与与物组的含量治疗基础上接受上下夹脊穴,阿穴,委中和山山治疗。腹针组腹针组体育针组均每日针刺1,每星期治疗6d,休息1d,共治疗3星期。于于前及治疗1,2,3星期间后行疼痛疼痛载量(视觉模拟量表,VAS)及barthel次数(Barthel Index,Bi)分支,分享到患者的疼痛程度及日常生命权力(日常生活活动,ADL) 。结果:治疗后,三组vas评及及及均均本组前前统计统计(p <0.05)。治疗1,2,3星期间,腹针组及体系VAS及及评评与与期末食物含有疗效差异(P <0.01)。治疗1,2星期间,腹针组VAS及BI评分改善优于体体(P <0.05);治疗3星期间,腹针组与体性的VAS分差异差异统计统计(p> 0.05),Bi评分子有效学差异(p <0.05)。结论:腹针腹针法在改善ovcf患者vas及bi评分方方面药物治疗,且具有起效,痛苦小的特价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号